Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Larimar Therapeutics (LRMR) Accumulated Depreciation & Amortization (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with $550000.0 as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Accumulated Depreciation & Amortization rose 8.27% year-over-year to $550000.0, compared with a TTM value of $550000.0 through Dec 2018, up 8.27%, and an annual FY2018 reading of $550000.0, up 8.27% over the prior year.
  • Accumulated Depreciation & Amortization was $550000.0 for Q4 2018 at Larimar Therapeutics, up from $508000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $550000.0 in Q4 2018 and bottomed at $50000.0 in Q4 2014.
  • Average Accumulated Depreciation & Amortization over 5 years is $309600.0, with a median of $320000.0 recorded in 2016.
  • The sharpest move saw Accumulated Depreciation & Amortization soared 166.67% in 2016, then rose 8.27% in 2018.
  • Year by year, Accumulated Depreciation & Amortization stood at $50000.0 in 2014, then soared by 140.0% to $120000.0 in 2015, then skyrocketed by 166.67% to $320000.0 in 2016, then soared by 58.75% to $508000.0 in 2017, then rose by 8.27% to $550000.0 in 2018.
  • Business Quant data shows Accumulated Depreciation & Amortization for LRMR at $550000.0 in Q4 2018, $508000.0 in Q4 2017, and $320000.0 in Q4 2016.